SCHEMBL13041008

SCHEMBL13041008

CN1CCN(Cc2ccc3ccccc3n2)CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.58
HRH4 Q9H3N8 3/20 0.55
KDM4E B2RXH2 2/20 0.55
HRH3 Q9Y5N1 2/20 0.55
HTR3E A5X5Y0 1/20 0.55
HTR3B O95264 1/20 0.55
ALDH1A1 P00352 1/20 0.55
CYP1A2 P05177 1/20 0.55
THPO P40225 1/20 0.55
HTR3A P46098 1/20 0.55
HTR3D Q70Z44 1/20 0.55
HTR3C Q8WXA8 1/20 0.55
HTR1A P08908 1/20 0.51
HTR7 P34969 1/20 0.51
MC4R P32245 1/20 0.50
CHKA P35790 1/20 0.49
MAPT P10636 2/20 0.48
NPC1 O15118 1/20 0.48
XBP1 P17861 1/20 0.48
RAB9A P51151 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1331611 1.00 FAAH (0.58) FAAHHRH4KDM4EHRH3HTR3E
SCHEMBL1331198 0.92 FAAH (0.65) FAAHHRH3HTR1AHTR7MAPT
SCHEMBL17289123 0.92 FAAH (0.65) FAAHHRH3HTR1AHTR7MAPT
SCHEMBL1972333 0.90 FAAH (0.50) FAAHHRH4KDM4EHRH3HTR3E
SCHEMBL1331766 0.87 HRH3 (0.63) FAAHHRH3CYP1A2HTR1AHTR7
SCHEMBL6584608 0.87 FAAH (0.60) FAAHKDM4EHRH3ALDH1A1CYP1A2
SCHEMBL11784176 0.86 KDM4E (0.54) FAAHHRH4KDM4EHRH3HTR3E
SCHEMBL23750987 0.84 FAAH (0.55) FAAHHRH3HTR1AHTR7MAPT
SCHEMBL7495658 0.84 FAAH (0.55) FAAHHRH3HTR1AHTR7MAPT
SCHEMBL27140396 0.83 FAAH (0.57) FAAHKDM4EALDH1A1CYP1A2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105814040-B The condensed 1,4- dihydro two of inhibitor as thermal excited transcryption factor 1 dislikes ene derivative 癌症研究科技有限公司 2019-07-30 CN disclosed
US-7829568-B2 Substituted 5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-2-ylamine compounds and their use for producing drugs GRUENENTHAL GMBH (DE) 2010-11-09 US disclosed
EP-1869038-B1 SUBSTITUTED 5,6,7,8-TETRAHYDRO-IMIDAZO[1,2-A]PYRIDIN-2-YLAMINE COMPOUNDS AND THEIR USE FOR PRODUCING DRUGS GRUENENTHAL GMBH (DE) 2009-07-08 EP disclosed
US-20080300256-A1 Substituted 5,6,7,8-Tetrahydroimidazo[1,2-a]pyridin-2-ylamine Compounds and Their Use for Producing Drugs GRUENENTHAL GMBH (DE) 2008-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080300256-A1 Substituted 5,6,7,8-Tetrahydroimidazo[1,2-a]pyridin-2-ylamine Compounds and Their Use for Producing Drugs CYP3A7, CYP3A5, CYP2D6 FAAH 2988/4885HRH4 271/4885KDM4E 1116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.